Last reviewed · How we verify
Lactic acid (Dermacid)
Lactic acid works as a keratolytic and exfoliating agent that dissolves and removes damaged outer skin layers to promote skin renewal and improve texture.
Lactic acid works as a keratolytic and exfoliating agent that dissolves and removes damaged outer skin layers to promote skin renewal and improve texture. Used for Ichthyosis and related keratinization disorders, Photoaged skin and hyperpigmentation.
At a glance
| Generic name | Lactic acid (Dermacid) |
|---|---|
| Sponsor | Sanofi |
| Drug class | Alpha-hydroxy acid (AHA) / Keratolytic agent |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Lactic acid is an alpha-hydroxy acid (AHA) that penetrates the stratum corneum and breaks down the bonds between dead skin cells, facilitating their removal. This exfoliating action stimulates cell turnover and collagen remodeling, improving skin appearance and treating conditions characterized by abnormal keratinization or hyperpigmentation. The mechanism is primarily chemical exfoliation rather than a receptor-mediated or enzymatic pathway.
Approved indications
- Ichthyosis and related keratinization disorders
- Photoaged skin and hyperpigmentation
Common side effects
- Skin irritation
- Erythema
- Burning or stinging sensation
- Dryness
Key clinical trials
- Dermacyd in Odor Reducing. (PHASE3)
- Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional (PHASE3)
- Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze (PHASE3)
- Dermacyd Delicata Breeze - Photo Evaluation (PHASE3)
- Dermatological Evaluation of Topic Compatibility - Dermacyd Breeze (PHASE3)
- Dermacyd Tina Gel Sweet Flower - Photo Evaluation (PHASE3)
- Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR (PHASE3)
- Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BR (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lactic acid (Dermacid) CI brief — competitive landscape report
- Lactic acid (Dermacid) updates RSS · CI watch RSS
- Sanofi portfolio CI